GlassScriptPhysician profile
David Villarreal
NPI 1861417552
$2,912.79
in general payments reported to CMS, 2019-2025
21 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $557 · 2022: $390 · 2023: $1,142 · 2024: $450 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $527.37 | 2021-2023 | Andexxa |
| Ethicon US, LLC | $350.61 | 2021-2023 | Ethicon, Echelon Flex |
| Acera Surgical, INC. | $311.74 | 2023-2025 | Restrata Wound Matrix |
| Kci USA, INC. | $239.85 | 2020-2021 | |
| Integra Lifesciences Corporation | $229.75 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $198.33 | 2021-2023 | Phasix Mesh |
| My01 INC. | $143.16 | 2022 | |
| Polynovo North America LLC | $126.56 | 2025 | Novosorb Btm |
| Medtronic, INC. | $118.02 | 2023 | Ligasure |
| Stryker Corporation | $101.59 | 2024 | Photonsaber F, Spy-Phi System, 1788 |
| Shockwave Medical, INC | $99.89 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tela Bio, INC. | $87.77 | 2022 | |
| Abbvie INC. | $80.00 | 2024 | |
| Octapharma USA, INC. | $65.35 | 2025 | Fibryga |
| Kls-Martin L.P. | $55.04 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $47.62 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Edwards Lifesciences Corporation | $34.32 | 2021 | |
| Ambu INC. | $31.91 | 2024 | |
| Merck Sharp & Dohme LLC | $22.65 | 2023 | Verquvo |
| Hikma Pharmaceuticals USA | $20.98 | 2023 | Ryaltris |
| Atricure, INC. | $20.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Villarreal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.